Previous Article | Next Article 
Journal of Virology, January 2000, p. 91-98, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Phosphoprotein of Rabies Virus Is
Phosphorylated by a Unique Cellular Protein Kinase and Specific
Isomers of Protein Kinase C
Ashim K.
Gupta,1
Danielle
Blondel,2
Suresh
Choudhary,1 and
Amiya
K.
Banerjee1,*
Department of Virology, Lerner Research
Institute, Cleveland Clinic Foundation, Cleveland, Ohio
44195,1 and Laboratoire de Genetique
des Virus, CNRS, 91198 Gif sur Yvette cedex, France2
Received 10 June 1999/Accepted 28 September 1999
 |
ABSTRACT |
The phosphoprotein (P) gene of rabies virus (CVS strain) was cloned
and expressed in bacteria. The purified protein was used as the
substrate for phosphorylation by the protein kinase(s) present in cell
extract prepared from rat brain. Two distinct types of protein kinases,
staurosporin sensitive and heparin sensitive, were found to
phosphorylate the P protein in vitro by the cell extract.
Interestingly, the heparin-sensitive kinase was not the ubiquitous
casein kinase II present in a variety of cell types. Further
purification of the cell fractions revealed that the protein kinase C
(PKC) isomers constitute the staurosporin-sensitive kinases
,
,
, and
, with the PKC
isomer being the most effective in
phosphorylating the P protein. A unique heparin-sensitive kinase was
characterized as a 71-kDa protein with biochemical properties not
demonstrated by any known protein kinases stored in the protein data
bank. This protein kinase, designated RVPK (rabies virus protein
kinase), phosphorylates P protein (36 kDa) and alters its mobility in
gel to migrate at 40 kDa. In contrast, the PKC isoforms do not change
the mobility of unphosphorylated P protein. RVPK appears to be packaged
in the purified virions, to display biochemical characteristics similar
to those of the cell-purified RVPK, and to similarly alter the mobility
of endogenous P protein upon phosphorylation. By site-directed
mutagenesis, the sites of phosphorylation of RVPK were mapped at
S63 and S64, whereas PKC isomers phosphorylated
at S162, S210, and S271.
Involvement of a unique protein kinase in phosphorylating rabies virus
P protein indicates its important role in the structure and function of the protein and consequently in the life cycle of the virus.
 |
INTRODUCTION |
Like viruses belonging to the
rhabdovirus and paramyxovirus family, Rabies virus (RV), a
member of Lyssavirus genus, contains a linear nonsegmented
RNA genome of negative polarity. The ribonucleoprotein (RNP) complex
contains the genome RNA enwrapped by the nucleocapsid protein (N) and
the RNA polymerase, which contains a large protein (L) and the
phosphoprotein (P) (1). Both L and P proteins of RV, like
the corresponding proteins in rhabdoviruses and paramyxoviruses, are
involved in the transcription and replication of the genome RNA
(1, 46). Although the L proteins of this class of viruses show significant similarity in amino acid sequence, the P proteins appear to be highly divergent and nonhomologous. However, all P
proteins are structurally similar in being highly acidic and phosphorylated and in playing a common vital role as transcription factors for the function of the corresponding L proteins. The P
proteins, in addition to providing the transcription function of the L
protein, appear to play an important role in the replicative process as
well (19, 22, 28, 34, 36). In this role, the P protein forms
a complex intracellularly with the N protein to impart an undefined
replication-competent form to the latter which enables it to
encapsidate nascent RNA chains during the replicative reaction
(12, 28, 35). Interestingly, phosphorylation of the P
protein appears not to be required for formation of this complex
(19, 42, 43), suggesting a possible involvement of
phosphorylation/dephosphorylation of P protein in the so-called switch
of the RNA polymerase from transcriptive to replicative mode. Thus, the
structures and functions of the P proteins of these viruses have been
the subject of studies in several laboratories.
In the recent past, a systematic effort has been made to characterize
the cellular protein kinases that phosphorylate the P proteins of these
viruses and to establish the role, if any, of this posttranslational
modification in P-protein function. Interestingly, a diverse group of
cellular kinases have been found to phosphorylate different P proteins
of this class of viruses (13, 15). For example, casein
kinase II (CKII) and an L-protein-associated protein kinase (LAK) are
specifically used for phosphorylation of the P protein of vesicular
stomatitis virus (VSV) (2, 3), whereas the protein kinase
C
(PKC
) isoform phosphorylates the P proteins of human
parainfluenza virus type 3 (HPIV3) and Sendai virus (14, 24,
25), although a unique proline-directed protein kinase has also
been shown to be involved in Sendai virus P-protein phosphorylation
(5). In contrast, both CKII and PKC
are used by measles
virus and canine distemper virus (11, 31) P proteins, and
the PKC
isomer is used for Borna virus P-protein phosphorylation (39). Involvement of specific cellular kinases for the
phosphorylation of different P proteins raises the important question
as to their precise roles in the structures and functions of these
proteins. Recently, by biochemical and reverse genetics approach, an
obligate role of phosphorylation in the P-protein function of VSV
(34) and HPIV3 (14, 25) has been established. For
other viral P proteins studied so far, the functional role of
phosphorylation remains to be firmly established.
In this work, we have studied phosphorylation of the RV P protein by
cellular kinases, using rat brain tissue homogenate as the source of
protein kinase and bacterially expressed P protein as the substrate. By
extensive purification of the cell extracts, we have purified a unique
heparin-sensitive non-CKII protein kinase that specifically
phosphorylates the RV P protein. The precise identity of this kinase
remains unknown. We also demonstrate that several isomers of PKC
phosphorylate P protein of RV. Among them, PKC
seems to be used
preferentially by the P protein. Both the unique protein kinase and PKC
isomers phosphorylate at specific sites on the P protein, resulting in
the formation of distinct phosphorylated forms of P protein
distinguishable by polyacrylamide gel electrophoresis (PAGE) analyses.
Interestingly, the unique protein kinase seems to be preferentially
packaged within the purified virions. The functional role of these
protein kinases in RV replication remains to be determined.
 |
MATERIALS AND METHODS |
Cell cultures and virus.
The CVS (challenge virus standard)
strain of RV was grown on BSR cells (a clone of BHK-21 cells) and
purified by centrifugation in a 10 to 40% sucrose gradient as
described elsewhere (40). For 35S labeling of
virus, cell culture medium was replaced 20 h after infection by
methionine-free minimal essential medium supplemented with 50 µCi of
[35S]methionine and [35S]cysteine (specific
activity, >1,000 Ci/mmol; Amersham) per ml for 24 h.
Expression of RV P protein in Escherichia coli.
The
cDNA clone of RV (CVS strain) P gene was subcloned into the bacterial
expression vector pET-3a as described earlier (2). For
expression, the positive recombinant plasmid was introduced into
E. coli BL21/DE3, and the expressed recombinant P protein was then purified through phosphocellulose and DE52 ion-exchange chromatography. All mutant P genes were similarly cloned, expressed, and purified.
Purification of cellular kinases from rat brain.
Rat brain
tissue homogenate was prepared, and an S100 fraction was made
(27). The S100 fraction was passed through a DEAE column
equilibrated with buffer A (25 mM Tris [pH 8.0], 7.5% sucrose, 1 mM
dithiothreitol [DTT], 0.5 mM EDTA) containing 0.12 M NaCl. Both the
unbound (DE-UB) and bound (DE-B) fractions (eluted with a 0.12 to 0.5 M
NaCl gradient in buffer A) were collected. The DE-UB fractions were
dialyzed against 25 mM potassium phosphate buffer (pH 7.5) containing 1 mM DTT and 5% glycerol and were loaded onto a hydroxylapatite column
equilibrated in the same phosphate buffer. Different isoforms of
conventional PKC were step eluted with 75, 100, and 150 mM potassium
phosphate buffer as described elsewhere (33). The peak
fraction from each step eluate was dialyzed in 25 mM potassium
phosphate buffer, rechromatographed through a hydroxylapatite column,
and processed similarly. The peak fractions containing kinase activity
were stored at
80°C. The DE-B fractions having the P-protein
phosphorylating activity were combined and passed through a
phosphocellulose column equilibrated with buffer A containing 0.2 M
NaCl. P-protein phosphorylating activity was collected in unbound
(PC-UB) and bound (PC-B) fractions (eluted at 0.6 M NaCl). The PC-B
fractions were then loaded onto a heparin-Sepharose column at 50 mM
NaCl salt concentration. The active fractions, eluted at 0.8 M NaCl,
were combined (HS-B1) and loaded onto a hydroxylapatite column
equilibrated with 50 mM potassium phosphate buffer (pH 7.5). P-protein
phosphorylating kinase binds to the column which can be eluted at 500 mM potassium phosphate buffer, pH 7.5 (HAP-B). The HAP-B fractions were
then rechromatographed through a heparin-Sepharose column. The active fractions eluted at 0.8 M NaCl were then combined (to form what we have
designated RVPK [RV protein kinase]) and stored at
80°C.
Protein kinase assay.
In vitro phosphorylation of P protein
was carried out in a 20-µl reaction containing 0.2 to 0.5 µg of
recombinant P protein, 5 µCi of [
32P]ATP, 50 µM
ATP, 50 mM Tris-HCl (pH 8.0), 2 mM MgCl2, 1 mM DTT, and the
indicated amount of kinase. To check the PKC activity, 200 µM
CaCl2, 100 µg of phosphatidylserine per ml, and 100 µg of diacylglycerol per ml were also added in the reaction buffer (33). The reaction mixture was incubated at 30°C for 30 min. The reaction was stopped by adding sodium dodecyl sulfate (SDS) sample loading buffer and electrophoresed on a 10% polyacrylamide gel
containing SDS. The gels were then subjected to autoradiography.
For assay of virion-associated protein kinase (RNPK) activity, purified
virions (2.0 µg) were disrupted with 0.1% Triton X-100 and incubated
with kinase reaction buffer (20 mM Tris-HCl (pH 8), 10 mM MgCl, 2 mM
DTT, 10 µCi of [
-32P]ATP, 50 µM unlabeled ATP) and
incubated at 30°C for 30 min. Reactions were stopped by adding SDS
sample loading buffer and analyzed by electrophoresis through an
SDS-12% polyacrylamide gel followed by autoradiography.
Quantification of radioactivity was performed with a PhosphorImager
(Molecular Dynamics). 35S-labeled virus or unlabeled virus
was incubated as previously described except that unlabeled ATP was
added in the reaction.
Peptide mapping of the phosphorylated P protein.
Either the
wild-type or mutant P protein was phosphorylated with RVPK (HAP-B
fraction) in the presence of [
-32P]ATP. The
radiolabeled P protein was electrophoresed through an SDS-10%
acrylamide gel and were visualized by brief autoradiography. The
32P-labeled bands were excised, electroeluted, and
concentrated. The 32P-labeled proteins were digested with
LysC or chymotrypsin essentially as described elsewhere (7).
The digests were then analyzed by electrophoresis in a 20%
polyacrylamide gel and autoradiographed (7).
 |
RESULTS |
Phosphorylation of E. coli-expressed P protein of RV by
fractionated tissue extract.
A full-length cDNA of RV (CVS strain)
P protein was expressed in E. coli by using an inducible
expression vector, pET3a, as described earlier (2). The
recombinant unphosphorylated P protein was purified by fractionation on
DEAE and phosphocellulose column chromatography and used in subsequent
reactions as the substrate for phosphorylation by the cellular protein
kinases purified from cell extract. Initially an S100 soluble extract
of rat brain was prepared and subjected to fractionation by
DEAE-cellulose and phosphocellulose chromatography as shown in Fig.
1A. Various bound and unbound fractions
from both column fractions were used to phosphorylate recombinant P
protein in the presence of [
-32P]ATP in vitro. In each
phosphorylation reaction, either heparin (an inhibitor of CKII) or
staurosporin (an inhibitor of PKC) was added to characterize the
protein kinase(s). As shown in Fig. 1B, although all fractions
efficiently phosphorylated RV Protein the protein kinases in fractions
DE-UB and PC-UB were sensitive to staurosporin, whereas fraction PC-B
was sensitive to heparin. These results strongly suggested that
fractions DE-UB and PC-UB contained PKC subtypes and fraction PC-B
contained CKII. Surprisingly, as shown in Fig. 1C, the P protein was
not phosphorylated by authentic CKII whereas commercial PKC effectively
phosphorylated it. We concluded from these results that the protein
kinase present in fraction PC-B is not CKII, although it is heparin
sensitive, and may represent a unique class of protein kinase. In
addition, recombinant unphosphorylated P protein of 36K kDa
(P36) migrated slower (as P40) in PAGE upon
phosphorylation by fraction PC-B (Fig. 1). The migration rate remained
unchanged when recombinant P protein was phosphorylated by fractions
DE-UB and PC-UB. Thus, it seems that different phosphorylated forms of
RV P protein are produced following phosphorylation by the different
protein kinases present in DE-UB, PC-UB, and PC-B fractions.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
Phosphorylation of recombinant P protein of RV by rat
brain extract. (A) Schematic presentation of the purification of
soluble extract (S100) by DEAE-cellulose and phosphocellulose (PC)
column chromatography rat brain tissue homogenate. The unbound (UB) and
bound (B) fraction from each column are noted in parentheses. (B)
Bacterially expressed recombinant P protein of RV was incubated with
[ -32P]ATP and different fractions, as indicated above
the lanes, in the absence ( ) or presence of heparin (H) or
staurosporine (S). The positions of migration of the phosphorylated P
proteins are indicated. (C) Recombinant P protein was incubated with
commercially available PKC or recombinant CKII.
|
|
Characterization of PKC isoforms in fractions DE-UB and PC-UB.
First, we fractionated further both DE-UB and PC-UB fractions by
chromatography on a hydroxylapatite column, and different isomers of
PKC (
,
, and
) were eluted by a sodium phosphate step
gradient. Each fraction (1, 2, and 3) was tested for different isomers
of PKC by Western blot analyses (Fig.
2A). Similarly, the PKC
normally
present in fraction PC-UB (13) was purified and analyzed by
Western blotting with authentic PKC
. As shown in Fig. 2A, fractions
1, 2, and 3 cross-reacted with PKC isoforms
,
, and
,
respectively, and PKC
antibodies reacted specifically with the PC-UB
fraction. The separation of these three isomers was absolute since no
fraction cross-reacted with another in Western blot analyses (Fig. 2A).
The purified PKC isoforms were then tested for phosphorylation activity
on P protein. As shown in Fig. 2B, all four isoforms of PKC
phosphorylated P protein but to different degrees. PKC
consistently
phosphorylated the P protein with the highest efficiency, followed by
,
, and
. In each assay, equal unit activity of each PKC
isoform, equalized on the basis of peptide phosphorylation by PKC
isomers, was used with an equivalent amount of P as substrate. These
results suggest that at least four isoforms of PKC are able to
phosphorylate the P protein, with PKC
being the most effective.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of the PKC isoforms purified from rat brain
extract by Western blotting and by phosphorylating activity. (A) Each
conventional isoform of PKC purified from the DE-UB fraction as
described in Materials and Methods was assayed for the presence of
conventional PKC isoforms ( , , and ) by Western blot analysis.
The antibody used for each blot is indicated at the top. Lanes 1, 2, and 3 represent fractions eluted with 75, 100, and 150 mM potassium
phosphate buffer, respectively. PKC , a novel isoform normally
present in the PC-UB fraction, was assayed by anti- antibody.
Positions of migration of molecular weight markers are shown in
kilodaltons on each side. (B) Recombinant P protein was incubated with
[ -32P]ATP and identical unit activity of different
isoforms of PKC, marked above each lane. Numbers at the bottom denote
percent phosphorylation, taking the highest level of phosphorylation by
PKC as 100%.
|
|
Purification and characterization of the heparin-sensitive protein
kinase.
Fraction PC-B (Fig. 1A) which contained the unique
heparin-sensitive non-CKII protein kinase, was subjected to a series of chromatographic purification steps as described in Materials and Methods. The final eluted fraction from the heparin-Sepharose column
was nearly homogeneous and efficiently phosphorylated the P protein in
vitro (not shown). It was then subjected to glycerol gradient
centrifugation followed by PAGE of the peak fraction. As shown in Fig.
3A, the protein kinase sedimented at a
position slightly higher than that of the control, bovine serum albumin (67 kDa). This is consistent with the PAGE analysis (Fig. 3B), where
the protein migrated slower than the 67-kDa marker, with a molecular
weight of approximately 71,000. From these analyses it seems that a
heparin-sensitive protein kinase (designated RVPK) with a molecular
weight of 71,000 is involved in the phosphorylation of P protein of RV,
in addition to specific PKC isoforms.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Determination of molecular weight of RVPK by glycerol
gradient centrifugation. (A) Purified RVPK obtained after the second
heparin-Sepharose column step, as detailed in Materials and Methods,
was loaded on a 5 to 25% glycerol gradient and run in an SW40 rotor at
36,000 rpm for 42 h at 4°C. Fractions (3 drops/fraction) were
collected from the bottom. Alternative fractions were assayed for the
ability to phosphorylate the P protein and plotted (squares); a
parallel gradient was run with the known molecular weight protein
mixture, and the optical densities at 280 nm of the fractions were
plotted (circles). The peak position of migration of each known
molecular weight protein is marked by an arrow. (B) Two fractions
showing highest protein kinase activity were analyzed on an SDS-10%
acrylamide gel and silver stained. Numbers on the left indicate
positions of migration (in kilodaltons) of molecular weight markers;
the number on the right indicates the deduced molecular mass of the
stained protein.
|
|
Different phosphorylated forms of RV P protein following
phosphorylation by kinases.
Having purified the PKC isoforms and
the heparin-sensitive RVPK from tissue homogenate, we next studied the
effect of phosphorylation on the electrophoretic mobility of the
recombinant P protein, which would indicate different phosphorylated
forms, if any, of the P protein. As shown in Fig.
4A, with increasing concentration of
RVPK, the P protein originally migrating as P36 shifted its mobility and migrated slower, as P40. In contrast, with
phosphorylation by any one of the PKC isoforms the migration position
of the P protein remained unchanged; i.e., it migrated as
P36. These results strongly suggest that phosphorylation by
RVPK and PKC isoforms led to the formation of different phosphorylated
forms of P protein in vitro. This effect of phosphorylation on the
mobility of P was more pronounced when different concentrations of P
protein were phosphorylated by a fixed amount of RVPK or PKC isoforms in the presence of unlabeled ATP followed by Western blot analyses with
25E6, a monoclonal antibody for P protein (38). As shown in
Fig. 4B, the unphosphorylated P migrating as P36 migrated
slower with increasing phosphorylation by RVPK, whereas the migration position of P remained virtually unchanged upon phosphorylation by PKC
isoforms. It is noteworthy that a slower-migrating minor band appears
slightly above either P36 or P40, depending on
the phosphorylation of P by PKC or RVPK (Fig. 4). However, the
slower-migrating band which appears upon phosphorylation by PKC (Fig.
4A) does not cross-react with the anti-P antibody (Fig. 4B). Again the slower-migrating band that appears after phosphorylation by RVPK in the
Western blot (Fig. 4B) is not detected by 32P assay (Fig.
4A). At this point, the precise identities of these bands are unknown.
Thus, it seems that two distinct phosphorylated forms of P protein are
formed upon phosphorylation by RVPK and PKC isomers.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 4.
Mobility of P protein following phosphorylation by
different kinases. (A) P protein (50 µg/ml) was incubated with
increasing concentrations of RVPK (HAP-B) fraction or PKC (DE-UB)
fraction (0.025, 0.05, 0.1, and 0.2 µg/µl) in the presence of
[ -32P]ATP. (B) Different concentration (0.1 µg/µl)
of either RVPK or PKC in the presence of unlabeled ATP. The reaction
mixture was then electrophoresed on an SDS-10% acrylamide gel
followed by Western blot analysis against P antibody, using ECL
reagent. Positions of migration of radiolabeled P protein are marked by
P36 and P40.
|
|
Characterization of RNPK in RV.
Protein kinases have been
found to be associated with the RNP of the purified virions of many
enveloped viruses (9, 18, 21, 26, 30, 32). It is generally
believed to be a phenomenon of random packaging of cellular kinases,
possibly during virus maturation. However, in the recent past, this
contention has changed particularly for VSV and HPIV3, where a
selective packaging of CKII and the PKC
isoform, respectively, the
protein kinases that are involved in phosphorylation of the
corresponding P proteins, was observed (14, 20). These
findings raised the possibility that RV also packages the
heparin-sensitive kinase and all or some of the PKC isoforms involved
in P phosphorylation. Accordingly, purified RV was disrupted by Triton
X-100 and incubated directly with [
-32P]ATP. As shown
in Fig. 5A, efficient phosphorylation of
RNP-associated P protein as well as N protein was observed; the latter
protein has previously been shown to be phosphorylated both in vitro
and in vivo (47). Interestingly, the RNPK was highly
sensitive to heparin but not to staurosporin. We did, however, observe
a low level of heparin-resistant activity, which may represent a low level of PKC activity within the virion. Moreover, disrupted RV did not
phosphorylate casein in vitro (not shown), indicating that the RNPK is
probably a unique protein kinase similar to RVPK purified from the cell
extract. To test whether the RNPK changes the mobility of the P protein
as observed for the RVPK purified from cell extract, a kinetic analyses
of the phosphorylation of endogenous virion P protein was carried out
in vitro. When we incubated 35S-labeled virus with
unlabeled ATP (Fig. 5B) or carried out Western blot analyses of
unlabeled virus with unlabeled ATP (C), we detected a time-dependent
shift of P protein mobility from P36 to P40
similar to that observed in Fig. 4. These results indicated that RV
selectively packaged the heparin-sensitive protein kinase during
maturation and remained associated with the RNP complex within the
virion. Western blotting of the RNPK with antibodies against PKC
isomers detected a small amount of PKC
subtype only (data not
shown).

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 5.
Phosphorylation of viral P protein with RNPK. (A)
Purified RV (25 µg/ml) was disrupted by Triton X-100 and incubated
with [ -32P]ATP in absence ( ) or presence of heparin
(25 µg/ml; H) or staurosporine (200 nM; S). Positions of migration of
N and P proteins are indicated. (B) [35S]Met-labeled
purified virus was similarly incubated with unlabeled ATP for different
time periods, indicated (in minutes) above the lanes. i,
[35S]Met-labeled infected cell RNP; P36 and
P40, positions of slower- and faster-migrating P protein,
respectively. (C) Purified RV (25 µg/ml) was incubated with unlabeled
ATP for different time periods as indicated (in minutes) above the
lanes. The samples were then run on an SDS-10% polyacrylamide gel
followed by Western blot analysis with anti-P antibody. i,
[35S]Met-labeled infected cell RNP; P and P', bacterially
expressed recombinant P protein phosphorylated with PKC (DE-UB) and
RVPK (HAP-B), respectively. Positions of migration of the
phosphorylated P proteins are indicated by P36 and
P40.
|
|
Next, we carried out a detailed biochemical characterization of the
RVPK for comparison with properties of the RNPK. As detailed in Table
1, virtually all biochemical parameters
tested were identical for the two enzymes. We conclude from these
results that the unique protein kinase is responsible for the
phosphorylation of P protein both in vitro and probably in vivo.
Determination of the phosphorylation sites on RVP.
We next
wanted to determine the site(s) of phosphorylation by RVPK and the PKC
isoforms on the P protein. From the amino acid sequence of P protein of
the CVS strain of RV, we first located the S and the T residues that
are present within the consensus motif of the PKC phosphorylation site,
i.e., S/T-X-K/R. This exercise led us to select four sites
(T149, S162, S210, and
S271) which are located within the PKC consensus motif. We
carried out systematic site-directed mutagenesis at those sites,
altering S or T to A, expressed the mutant proteins in E. coli, and then purified and tested them for phosphorylation by
RVPK and PKC. As shown in Fig. 6,
altering S162 and S210 to A resulted in a
drastic reduction in the ability of PKC to phosphorylate P protein
(95%), whereas phosphorylation by RVPK was reduced by only 25%. These
results suggest that PKC phosphorylation sites are probably
S162, S210, and S271, which are
presumably different from the RVPK sites which may be located at a
different domain in the P protein.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Determination of P phosphorylation sites for RVPK. (A) A
diagram of the entire P protein is shown at the left hand; the dots
represent computer-predicted PKC sites. An enlargement of that region
shows the positions of one threonine (T) and three serine (S) residues.
The mutant P proteins at these sites are shown. PpkcA is
the mutant P protein in which all four sites were changed to alanine.
Phosphorylation of each mutant as a percentage of the wild-type level
is shown at the right. PKC (DE-UB) and RVPK (HS-B) were used for
analyses. (B) The entire P protein is drawn schematically along with
the computer-predicted PKC sites. Subscript numbers in C-terminal
mutant designations represent the number of amino acids deleted from
the C terminus. The mutated serines and threonine in the PKC motif are
shown. The number in the subscript of each N-terminal mutant
designation denotes the position of serine altered to alanine, keeping
the PKC motifs unaltered. Percent phosphorylation of each mutant by
purified RVPK (HAP-B) is shown at the right.
|
|
We then carried out a systematic deletion mapping of the RVPK
phosphorylation site(s) by progressive deletion from the C-terminal end
of the P protein. As shown in Fig. 6B, the mutant PC
206, which lacked all of the PKC sites, could still be phosphorylated efficiently (75%) by RVPK. Examination of the remaining N-terminal fragment revealed the presence of four S residues located at positions 2, 9, 63, and 64 which may the potential sites for RVPK. Since no
phosphorylated threonine residue was detected by phosphoamino acid
analysis, (data not shown), we did not include the threonine residues
present in the 91-amino-acid long N-terminal fragment for mutational
analysis. By site-directed mutagenesis of the above serine residues to
alanine, it was found that both S63 and S64 are
the probable sites of phosphorylation by RVPK (Fig. 6B). Thus, the
phosphorylation sites of RVPK and PKC are located at the N- and
C-terminal regions of the P protein, respectively.
Since both wild-type P (Pwt) and the deletion mutant
PC
206 can be phosphorylated almost equally by RVPK, RVPK
may phosphorylate Pwt at sites different from those in
PC
206; the latter sites may have been exposed due to
deletion of 206 amino acids from the carboxy terminus. To test this, we
phosphorylated both Pwt and PC
206 by RVPK;
then the eluted labeled proteins were digested with chymotrypsin or
LysC and subjected to gel electrophoresis. As shown in Fig.
7, virtually all peptides migrated
identically, demonstrating that both Pwt and
PC
206 are phosphorylated by RVPK at identical sites,
i.e., S63 and S64.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 7.
Peptide mapping of the phosphorylated P protein.
32P-labeled Pwt and PC 206
phosphorylated by RVPK (HAP-B) were gel purified as described in
Materials and Methods. Each labeled protein was then digested with
either LysC or chymotrypsin (CT), as shown above each lane.
|
|
 |
DISCUSSION |
In this study, we identified and characterized the cellular
protein kinases involved in the phosphorylation of recombinant rabies
virus (CVS strain) P protein, the transcription factor subunit of the
RNA polymerase complex. Similar studies on bacterially expressed P
protein of nonsegmented negative-strand RNA viruses revealed the
involvement of a diverse class of protein kinases responsible for
phosphorylating the transcription factors. These enzymes ranged from
the ubiquitous cellular protein kinase CKII to rare PKC isoforms
and
(4, 14, 24, 31, 39). Our present study demonstrated
that in addition to several isomers of PKC, the RV P protein utilizes
for its phosphorylation a unique heparin-sensitive non-CKII protein
kinase which appears to be selectively packaged within the matured
virions. The unique protein kinase (designed RVPK) is a 71-kDa
polypeptide that is sensitive to heparin and sphingosine, requires
specifically Mg2+, and is optimally active at an ATP
concentration of 2 mM. We have so far been unable to identify this
protein kinase by comparing its biochemical properties with those of
other known cellular protein kinases in the protein data bank. Clearly,
determination of the amino acid sequence of this kinase is essential to
find a match with a protein which may or may not turn out to be a bona fide protein kinase.
Our interesting finding is that RVPK seems to be directly involved in
altering the secondary structure of P protein such that it migrates
slower than the unphosphorylated or PKC isomer-phosphorylated P protein
(Fig. 4). In RV virions as well as in infected cells, two
phosphorylated forms of RV P proteins have been found: a so-called hyperphosphorylated form (P40) and a hypophosphorylated
form (P36). Also observed are several minor forms,
P35, P31, and P30, which appear to
be smaller N-terminally truncated products apparently resulting from
translation initiation at alternate AUG codons located in frame within
the P protein (8). The P36 form is found as the
principal product both in the virion and in infected cells
(45). The P40 form appears to be present
transiently during normal infection but accumulates when cells are
treated with okadaic acid, an inhibitor of protein phosphatases
(44). Thus, it seems that P40 and
P36 phosphorylated forms are interconvertible, and our data
suggest that the two forms are produced upon phosphorylation by RVPK
and PKC isomers, respectively. In this respect, the RV P protein is
similar to the VSV P protein studied previously (7), where
the phosphorylated P1 and P2 forms are produced upon phosphorylation by
CKII and LAK, respectively (2, 7). In earlier studies, expression of RV P protein in insect cells by infection of recombinant baculovirus yielded P protein which was not phosphorylated
(37). This may have been due to dephosphorylation of P
protein in vivo by active cellular phosphatases present in the insect
cells or due to the absence of a specific kinase. It is important to
note that although we purified RVPK from rat brain tissue homogenate, it is present in BHK cells in which RV is grown (data not shown). Thus,
selective utilization of this kinase strongly suggests its role in the
structure and function of the P protein.
The involvement of PKC isomers in RV P phosphorylation, on the other
hand, is also quite interesting. Although four isomers (
,
,
,
and
) appear to be involved in the phosphorylation process, the
isomer consistently appears to be used in preference to the other
three. Since PKC
activity is found predominantly in the brain and
the
and
isomers are present in all cell types, involvement of
PKC
may suggest the possible neurotropism routinely observed during
RV infection (6, 16, 41, 46). Another possibility could be
that because RV is neurotropic for another reason, its P protein is
predominantly phosphorylated by PKC
.
Another interesting finding is the specific packaging of RVPK within
the mature RV virions. It is apparent from Table 1 that RNPK
demonstrated biochemical properties identical to those of the RVPK
purified from brain tissue homogenate. Moreover, it phosphorylated in
vitro the endogenous P protein to generate two phosphorylated forms,
P36 and P40, similar to the purified RVPK (Fig.
3). In addition to RVPK activity, a small amount of PKC
was found in the virions of the CVS strain by Western blot analysis (data not shown). These findings are similar to those for VSV, HPIV3, and Sendai
virus, which also package the protein kinases involved in P-protein
phosphorylation. Thus, it seems that the specific kinases interact with
the viral P proteins of nonsegmented negative-strand viruses during
replication and remain associated with the virions during
morphogenesis. It is important to point out that these studies were
carried out with the CVS strain of RV grown in BHK cells. It is quite
possible that different strains of RV grown in different cell lines may
package different protein kinases involved in that particular
virus-host system.
Finally, it is apparent from our site-directed mutagenesis studies that
sites of phosphorylation of RVPK and PKC isomers are at opposite ends
of the P protein, N and C terminal, respectively. Phosphorylation at
the N-terminal end must lead to some conformational change in the P
protein leading to slower migration in PAGE (Figs. 4 and 5). In
contrast, C-terminal phosphorylation does not cause any such change in
the electrophoretic mobility of P protein. This situation is highly
analogous to that for the VSV P protein, where CKII phosphorylation
produces only the P1 form and LAK-mediated phosphorylation yields the
P2 form (2, 7, 23). Thus, it may be incorrect to consider
the P40 form of RV the hyperphosphorylated from since
phosphorylation of only two sites in the P protein resulted in the
formation of P40. It is possible that, as for VSV,
phosphorylation of the RV P protein causes a distinct change in the
structural property of the protein which may lead to its proper
association with the L protein. In fact, for VSV P (New Jersey
serotype), biophysical measurements confirmed that phosphorylation altered the secondary structure of the protein (10). In
addition, phosphorylation of VSV P (both Indiana and New Jersey
serotypes) results in oligomerization of the protein, leading
eventually to its activation (10, 17). Similar studies with
RV P protein would certainly provide some insight into the structure of
the protein as it relates to its function. It is important to mention here that unlike P of the CVS strain, P of the HEP-Flurry strain of RV
does not contain an S residue at position 63. Since a heparin-sensitive protein kinase has recently been implicated in phosphorylating the P
protein of this strain (44), it is likely that
S64 is the principal phosphorylation site for RVPK. This
predication can be confirmed by mutational analyses. Interestingly, P
proteins of the PV, PM, and ERA strains of RV all have only
S63, although the ERA strain has T at position 64 (4,
29). Involvement of RVPK in these strains is yet to be
established. Notwithstanding, active phosphorylation of S63
and S64 of the P protein of the CVS strain coupled with the
fact that RVPK is predominately packaged within the virion strongly
suggests that this unique protein kinase plays a role in the life cycle
of RV. Further studies along this line would clearly be informative.
 |
ACKNOWLEDGMENTS |
This work was supported by an NIH grant to A.K.B. and by CNRS UPR 9053.
We are grateful to Anne Flamand for helpful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Virology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., NC20, Cleveland, OH 44195. Phone: (216) 444-0625. Fax:
(216) 444-0512. E-mail: banerja{at}ccf.org.
 |
REFERENCES |
| 1.
|
Banerjee, A. K.,
S. Barik, and B. P. De.
1991.
Gene expression of nonsegmented negative strand RNA viruses.
Pharmacol. Ther.
51:47-70[CrossRef][Medline].
|
| 2.
|
Barik, S., and A. K. Banerjee.
1992.
Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation.
J. Virol.
66:1109-1118[Abstract/Free Full Text].
|
| 3.
|
Barik, S., and A. K. Banerjee.
1992.
Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein.
Proc. Natl. Acad. Sci. USA
89:6570-6574[Abstract/Free Full Text].
|
| 4.
|
Byrappa, S.,
Y. B. Pan, and K. C. Gupta.
1996.
Sendai virus P protein is constitutively phosphorylated at serine 249: high phosphorylation potential of the P protein.
Virology
216:228-234[CrossRef][Medline].
|
| 5.
|
Charlton, K. M., and G. A. Casey.
1979.
Experimental rabies in skunks. Immunofluorescence light and electron microscope studies.
Lab. Investig.
41:36-44[Medline].
|
| 6.
|
Chen, J. L.,
T. Das, and A. K. Banerjee.
1997.
Phosphorylated status of vesicular stomatitis virus P protein in vitro and in vivo.
Virology
228:200-212[CrossRef][Medline].
|
| 7.
|
Chenik, M.,
K. Chebli, and D. Blondel.
1995.
Translation initiation at alternate in-frame AUG codons in the rabies virus phosphoprotein mRNA is mediated by a ribosomal leaky scanning mechanism.
J. Virol.
69:707-712[Abstract].
|
| 8.
|
Clinton, G. M.,
B. W. Burge, and A. S. Huang.
1979.
Phosphoproteins of VSV: identity and interconversion of phosphorylated forms.
Virology
99:84-94[CrossRef][Medline].
|
| 9.
|
Clinton, G. M.,
N. G. Guerina,
H. Guo, and A. S. Huang.
1982.
Host-dependent phosphorylation and kinase activity associated with vesicular stomatitis virus.
J. Virol.
257:3313-3319.
|
| 10.
|
Das, T.,
A. K. Gupta,
P. W. Sims,
C. A. Gelfand,
J. E. Jentoft, and A. K. Banerjee.
1995.
Role of cellular casein kinase II in the function of the phosphoprotein (P) subunit of RNA olymerase of vesicular stomatitis virus.
J. Biol. Chem.
270:24100-24107[Abstract/Free Full Text].
|
| 11.
|
Das, T.,
A. Shuster,
S. Schneider-Schaulies, and A. K. Banerjee.
1995.
Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites.
Virology
211:218-226[CrossRef][Medline].
|
| 12.
|
Davis, N. L.,
H. Arnheiter, and G. W. Wertz.
1986.
Vesicular stomatitis virus N and NS proteins from multiple complexes.
J. Virol.
59:751-754[Abstract/Free Full Text].
|
| 13.
|
De, B. P., and A. K. Banerjee.
1997.
Role of host proteins in gene expression of negative strand RNA viruses.
Adv. Virus Res.
48:169-204[Medline].
|
| 14.
|
De, B. P.,
S. Gupta,
S. Gupta, and A. K. Banerjee.
1995.
Cellular protein kinase C isoform regulates human parainfluenza virus type 3 replication.
Proc. Natl. Acad. Sci. USA
92:5204-5208[Abstract/Free Full Text].
|
| 15.
|
De, B. P.,
T. Das, and A. K. Banerjee.
1997.
Role of cellular kinases in the gene expression of negative strand RNA viruses.
Biol. Chem.
378:489-493[Medline].
|
| 16.
|
Dietzschold, B.,
T. J. Wiktor,
J. Q. Trojanowski,
R. I. Macfarlan,
W. H. Wunner,
M. J. Torres-Anjel, and H. Koprowski.
1985.
Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.
J. Virol.
56:12-18[Abstract/Free Full Text].
|
| 17.
|
Gao, Y., and J. Lenard.
1995.
Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase II.
EMBO J.
14:1240-1247[Medline].
|
| 18.
|
Grubman, M. J.,
B. Baxt,
J. L. La Torre, and H. L. Bachrach.
1981.
Identification of a protein kinase activity in purified foot-and-mouth disease virus.
J. Virol.
39:455-462[Abstract/Free Full Text].
|
| 19.
|
Gupta, A. K., and A. K. Banerjee.
1997.
Expression and purification of vesicular stomatitis virus N-P complex from Escherichia coli: role in genome RNA transcription and replication in vitro.
J. Virol.
71:4264-4271[Abstract].
|
| 20.
|
Gupta, A. K.,
T. Das, and A. K. Banerjee.
1995.
Casein kinase II is the P protein phosphorylating cellular kinase associated with the ribonucleoprotein complex of purified vesicular stomatitis virus.
J. Gen. Virol.
76:365-372[Abstract/Free Full Text].
|
| 21.
|
Hatanaka, M.,
E. Twiddy, and R. V. Gilden.
1972.
Protein kinase associated with RNA tumor viruses and other budding RNA viruses.
Virology
47:536-538[CrossRef][Medline].
|
| 22.
|
Howard, M.,
N. Davis,
J. Patton, and G. Wertz.
1987.
Roles of vesicular stomatitis virus N and NS protein in viral RNA replication, p. 134-140.
In
B. W. J. Mahy, and D. Kolakofsky (ed.), The biology of negative strand viruses. Elsevier, Amsterdam, The Netherlands
|
| 23.
|
Hsu, C. H., and D. W. Kingsbury.
1982.
NS phosphoprotein of vesicular stomatitis virus: subspecies separated by electrophoresis and isoelectric focusing.
J. Virol.
42:342-345[Abstract/Free Full Text].
|
| 24.
|
Huntley, C. C.,
B. P. De, and A. K. Banerjee.
1997.
Phosphorylation of Sendai virus phosphoprotein by cellular protein kinase C .
J. Biol. Chem.
272:16578-16584[Abstract/Free Full Text].
|
| 25.
|
Huntley, C. C.,
B. P. De, and A. K. Banerjee.
1995.
Human parainfluenza virus type 3 phosphoprotein: identification of serine 333 as the major site for PKC phosphorylation.
Virology
211:561-567[CrossRef][Medline].
|
| 26.
|
Imblum, R. L., and R. R. Wagner.
1974.
Protein kinase and phosphorylation of vesicular stomatitis virus.
J. Virol.
13:113-124[Abstract/Free Full Text].
|
| 27.
|
Kikkawa, U.,
Y. Takai,
R. Minakuchi,
S. Inohara, and Y. Nishizuka.
1982.
Calcium activated phospholipid dependent protein kinase from rat brain.
J. Biol. Chem.
257:13341-13348[Free Full Text].
|
| 28.
|
La Ferla, F. M., and R. W. Peluso.
1989.
The 1:1 N-NS complex of vesicular stomatitis virus is essential for efficient genome replication.
J. Virol.
63:3852-3857[Abstract/Free Full Text].
|
| 29.
|
Larson, J. K., and W. H. Wunner.
1990.
Nucleotides ans deduced amino-acid sequences of the nominal nonstructural phosphoprotein of the ERA, PM and CVS-11 strains of rabies virus.
Nucleic Acids Res.
18:7172[Free Full Text].
|
| 30.
|
Lemaster, S., and B. Roizman.
1980.
Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virus.
J. Virol.
35:798-811[Abstract/Free Full Text].
|
| 31.
|
Liu, Z.,
C. C. Huntley,
B. P. De,
T. Das,
A. K. Banerjee, and M. J. Oglesbee.
1997.
Phosphorylation of canine distemper virus P protein by protein kinase C- and casein kinase II.
Virology
232:198-206[CrossRef][Medline].
|
| 32.
|
Moyer, S. A., and D. F. Summers.
1974.
Phosphorylation of vesicular stomatitis virus in vivo and in vitro.
J. Virol.
13:455-465[Abstract/Free Full Text].
|
| 33.
|
Ogita, K.,
Y. Ono,
U. Kikkawa, and Y. Nishizuka.
1991.
Expression separation and assay of protein kinase C subspecies.
Methods Enzymol.
200:228-234[Medline].
|
| 34.
|
Pattnaik, A. K.,
L. Hwang,
T. Li,
N. England,
M. Mathur,
T. Das, and A. K. Banerjee.
1997.
Phosphorylation within the amino-terminal acidic domain I of the phosphoprotein of vesicular stomatitis virus is required for transcription but not for replication.
J. Virol.
71:8167-8175[Abstract].
|
| 35.
|
Peluso, R. W.
1988.
Kinetic, quantitative, and functional analysis of multiple forms of vesicular stomatitis virus nucleocapsid protein in infected cells.
J. Virol.
62:2799-2807[Abstract/Free Full Text].
|
| 36.
|
Peluso, R. W., and S. A. Moyer.
1988.
Viral proteins required for the in vitro replication of vesicular stomatitis virus defective interfering particle genome RNA.
Virology
162:369-376[CrossRef][Medline].
|
| 37.
|
Prehaud, C.,
K. Nel, and D. L. Bishop.
1992.
Baculovirus expressed rabies virus M1 protein is not phosphorylated: it forms multiple complexes with expressed rabies N protein.
Virology
189:766-770[CrossRef][Medline].
|
| 38.
|
Raux, H.,
F. Iseni,
F. Lafay, and D. Blondel.
1997.
Mapping of monoclonal antibody epitopes of the rabies virus P protein.
J. Gen. Virol.
78:119-124[Abstract].
|
| 39.
|
Schwemmle, M.,
B. P. De,
L. Shi,
A. K. Banerjee, and I. Lipkin.
1997.
Borna disease virus P protein is phosphorylated by a calcium independent protein kinase C and casein kinase II.
J. Biol. Chem.
272:21818-21823[Abstract/Free Full Text].
|
| 40.
|
Seif, I.,
P. Coulon,
E. Rollin, and A. Flamand.
1985.
Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoproteins.
J. Virol.
53:926-934[Abstract/Free Full Text].
|
| 41.
|
Shankar, V.,
B. Dietzschold, and H. Koprowski.
1991.
Direct entry of rabies virus into the central nervous system without prior local replication.
J. Virol.
65:2736-2738[Abstract/Free Full Text].
|
| 42.
|
Takacs, M. A.,
T. Das, and A. K. Banerjee.
1993.
Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two hybrid system.
Proc. Natl. Acad. Sci. USA
90:10375-10379[Abstract/Free Full Text].
|
| 43.
|
Takacs, M. A., and A. K. Banerjee.
1995.
Efficient interaction of the vesicular stomatitis virus P protein with the L protein and the N protein in cells expressing the recombinant proteins.
Virology
208:821-826[CrossRef][Medline].
|
| 44.
|
Takamatsu, F.,
N. Asakawa,
K. Morimoto,
Y. Eriguchi,
H. Toriumi, and A. Kawai.
1998.
Possible relationship between the two forms of the non-catalytic subunit (P protein).
Microbiol. Immunol.
42:761-771[Medline].
|
| 45.
|
Tuffereau, C.,
S. Fischer, and A. Flammand.
1985.
Phosphorylation of the N and M1 proteins of rabies virus.
J. Gen. Virol.
66:2285-2289[Abstract/Free Full Text].
|
| 46.
|
Wagner, R. R.
1990.
Rhabdoviridae and their replication, p. 867-881.
In
D. M. Knipe, and B. N. Fields (ed.), Fields virology. Raven Press Ltd., New York, N.Y
|
| 47.
|
Yang, J.,
H. Koprowski,
B. Dietzschold, and Z. F. Fu.
1999.
Phosphorylation of rabies virus nucleoprotein regulates viral RNA transcription and replication by modulating leader RNA encapsidation.
J. Virol.
73:1661-1664[Abstract/Free Full Text].
|
Journal of Virology, January 2000, p. 91-98, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vidy, A., El Bougrini, J., Chelbi-Alix, M. K., Blondel, D.
(2007). The Nucleocytoplasmic Rabies Virus P Protein Counteracts Interferon Signaling by Inhibiting both Nuclear Accumulation and DNA Binding of STAT1. J. Virol.
81: 4255-4263
[Abstract]
[Full Text]
-
Marston, D. A., McElhinney, L. M., Johnson, N., Muller, T., Conzelmann, K. K., Tordo, N., Fooks, A. R.
(2007). Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3' non-translated region. J. Gen. Virol.
88: 1302-1314
[Abstract]
[Full Text]
-
Vidy, A., Chelbi-Alix, M., Blondel, D.
(2005). Rabies Virus P Protein Interacts with STAT1 and Inhibits Interferon Signal Transduction Pathways. J. Virol.
79: 14411-14420
[Abstract]
[Full Text]
-
Brzozka, K., Finke, S., Conzelmann, K.-K.
(2005). Identification of the Rabies Virus Alpha/Beta Interferon Antagonist: Phosphoprotein P Interferes with Phosphorylation of Interferon Regulatory Factor 3. J. Virol.
79: 7673-7681
[Abstract]
[Full Text]
-
Finke, S., Mueller-Waldeck, R., Conzelmann, K.-K.
(2003). Rabies virus matrix protein regulates the balance of virus transcription and replication. J. Gen. Virol.
84: 1613-1621
[Abstract]
[Full Text]
-
Toriumi, H., Honda, Y., Morimoto, K., Tochikura, T. S., Kawai, A.
(2002). Structural relationship between nucleocapsid-binding activity of the rabies virus phosphoprotein (P) and exposure of epitope 402-13 located at the C terminus. J. Gen. Virol.
83: 3035-3043
[Abstract]
[Full Text]
-
Jacob, Y., Real, E., Tordo, N.
(2001). Functional Interaction Map of Lyssavirus Phosphoprotein: Identification of the Minimal Transcription Domains. J. Virol.
75: 9613-9622
[Abstract]
[Full Text]
-
Raux, H., Flamand, A., Blondel, D.
(2000). Interaction of the Rabies Virus P Protein with the LC8 Dynein Light Chain. J. Virol.
74: 10212-10216
[Abstract]
[Full Text]
-
Gigant, B., Iseni, F., Gaudin, Y., Knossow, M., Blondel, D.
(2000). Neither phosphorylation nor the amino-terminal part of rabies virus phosphoprotein is required for its oligomerization. J. Gen. Virol.
81: 1757-1761
[Abstract]
[Full Text]
-
Vihinen, H., Saarinen, J.
(2000). Phosphorylation Site Analysis of Semliki Forest Virus Nonstructural Protein 3. J. Biol. Chem.
275: 27775-27783
[Abstract]
[Full Text]
-
Vihinen, H., Ahola, T., Tuittila, M., Merits, A., Kaariainen, L.
(2001). Elimination of Phosphorylation Sites of Semliki Forest Virus Replicase Protein nsP3. J. Biol. Chem.
276: 5745-5752
[Abstract]
[Full Text]